Medicines and Healthcare products Regulatory Agency
1: Authorisation Number | UK MIA(IMP) 4543 |
---|---|
2: Name of authorisation holder | CP PHARMACEUTICALS LIMITED |
3: Address(es) of manufacturing site(s) |
CP PHARMACEUTICALS LIMITED, ASH ROAD NORTH, WREXHAM, LL13 9UF, UNITED KINGDOM |
4: Legally registered address of authorisation holder | CP PHARMACEUTICALS LIMITED, ASH ROAD NORTH, WREXHAM, LL13 9UF, UNITED KINGDOM |
5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
6: Legal Basis of authorisation | |
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
8: Authorisation Date | 17/05/2021 |
9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
CP PHARMACEUTICALS LIMITED, ASH ROAD NORTH, WREXHAM, LL13 9UF, UNITED KINGDOM
Human Investigational Medicinal Products
Authorised Operations |
MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
Part 1 - MANUFACTURING OPERATIONS |
[ 1.1 ] Sterile Investigational Medicinal Products |
[ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
[ 1.1.1.2 ] Lyophilisates |
[ 1.1.1.4 ] Small volume liquids |
[ 1.1.2 ] Terminally Sterilised (processing operations for the following dosage forms) |
[ 1.1.2.3 ] Small volume liquids |
[ 1.1.3 ] Batch certification |
[ 1.2 ] Non-sterile investigational medicinal products |
[ 1.2.2 ] Batch certification |
[ 1.3 ] Biological investigational medicinal products |
[ 1.3.1 ] Biological medicinal products |
[ 1.3.1.5 ] Biotechnology products |
[ 1.3.1.6 ] Human or animal extracted products |
[ 1.3.1.8 ] Other biological medicinal products Manufacture of products based on botanical extracts and hormones. |
[ 1.3.2 ] Batch certification |
[ 1.3.2.5 ] Biotechnology products |
[ 1.3.2.6 ] Human or animal extracted products |
[ 1.3.2.8 ] Other biological medicinal products Manufacture of products based on botanical extracts and hormones. |
[ 1.4 ] Other investigational medicinal products or manufacturing activitiy |
[ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
[ 1.4.2.1 ] Filtration |
[ 1.4.2.2 ] Dry heat |
[ 1.4.2.3 ] Moist heat |
[ 1.6 ] Quality control testing |
[ 1.6.1 ] Microbiological: sterility |
[ 1.6.2 ] Microbiological: non-sterility |
[ 1.6.3 ] Chemical/Physical |
[ 1.6.4 ] Biological |
Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
[ 2.1 ] Quality control testing of imported medicinal products |
[ 2.1.1 ] Microbiological: sterility |
[ 2.1.2 ] Microbiological: non-sterility |
[ 2.1.3 ] Chemical/Physical |
[ 2.1.4 ] Biological |
[ 2.2 ] Batch certification of imported medicinal products |
[ 2.2.1 ] Sterile Products |
[ 2.2.1.1 ] Aseptically prepared |
[ 2.2.1.2 ] Terminally sterilised |
[ 2.2.2 ] Non-sterile products |
[ 2.2.3 ] Biological medicinal products |
[ 2.2.3.5 ] Biotechnology products |
[ 2.2.3.6 ] Human or animal extracted products |
[ 2.3 ] Other Importation Activities |
[ 2.3.1 ] Site of Physical Importation |